Sequential Cytarabine and  -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

Title
Sequential Cytarabine and  -Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 16, Issue 21, Pages 5303-5311
Publisher
American Association for Cancer Research (AACR)
Online
2010-09-22
DOI
10.1158/1078-0432.ccr-10-0382

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started